We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Observational Study - ILM Peeling

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01083056
Recruitment Status : Completed
First Posted : March 9, 2010
Last Update Posted : July 31, 2014
Information provided by (Responsible Party):

Study Description
Brief Summary:
This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.

Condition or disease
Epimacular Gliosis Macular Hole

Study Design

Study Type : Observational
Actual Enrollment : 10 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling
Study Start Date : March 2010
Primary Completion Date : July 2014
Study Completion Date : July 2014
Groups and Cohorts

Epimacular Gliosis Without Macular Hole
Epimacular Gliosis With Macular Hole

Outcome Measures

Primary Outcome Measures :
  1. BCVA [ Time Frame: 6 months after ILM peeling ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Inpatients at the University Eye Hospital Tuebingen

Inclusion Criteria:

  • Clinical diagnosis of Epimacular Gliosis
  • Must be scheduled for ILM-peeling independently of study
  • Must be older then 18 years of age

Exclusion Criteria:

  • Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
  • Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01083056

Centre for Ophthalmology, University Hospital Tuebingen
Tuebingen, BW, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
Principal Investigator: Florian Gekeler, MD Centre for Ophthalmology, University Hospital Tuebingen
More Information

Responsible Party: M. Dominik Fischer, PD Dr. med. M. Dominik Fischer, University Hospital Tuebingen
ClinicalTrials.gov Identifier: NCT01083056     History of Changes
Other Study ID Numbers: ILM Peeling
First Posted: March 9, 2010    Key Record Dates
Last Update Posted: July 31, 2014
Last Verified: July 2014

Keywords provided by M. Dominik Fischer, University Hospital Tuebingen:

Additional relevant MeSH terms:
Retinal Perforations
Retinal Diseases
Eye Diseases
Pathologic Processes